Skip to content

Clinical trials

Phase 2 Small Cell Lung Carcinoma trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Phase: Phase 2 Country / region: United Kingdom Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20062
20071
20091
20113
20151
20161
20172
20191
20201
20211
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated6
Active, not recruiting3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene3
Amgen2
Eli Lilly and Company2
Astellas Pharma Inc1
AstraZeneca1
BioNTech SE1
Boehringer Ingelheim1
Cambridge University Hospitals NHS Foundation Trust1
ETOP IBCSG Partners Foundation1
European Organisation for Research and Treatment of Cancer - EORTC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma20
Carcinoma, Non-Small-Cell Lung4
Melanoma4
Breast Neoplasms2
Carcinoma, Small Cell2
Neoplasms2
Ovarian Neoplasms2
Pancreatic Neoplasms2
Prostatic Neoplasms2
Squamous Cell Carcinoma of Head and Neck2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.